Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01238120 · ClinicalTrials.gov registry record · Phase 2
The Effects of Physical Activity and Low-Dose Ibuprofen on Cognitive Function in Cancer Patients
A Phase 2 study, sponsored by University of Rochester.
- Completed
- Registry status
- Phase 2
- Development phase
- 110
- Enrollment target
NCT01238120 is a Phase 2 study that has completed, run by University of Rochester. The registered enrollment target is 110 participants.
The verdict
NCT01238120, a Phase 2 study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 110 participants
- Enrollment target
Study Summary
This research seeks to determine if a combination of low-dose ibuprofen along with a structured home-based walking and progressive resistance exercise program, EXCAP, will be effective in reducing cognitive difficulties among cancer patients receiving chemotherapy.
Interventions
- DRUG Placebo
- DRUG Ibuprofen
- BEHAVIORAL Home-Based Exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2010-11 |
| Est. Completion | 2020-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01238120
The ClinicalTrials.gov registry entry for NCT01238120 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01238120 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01238120 about?
NCT01238120 is a clinical study titled "The Effects of Physical Activity and Low-Dose Ibuprofen on Cognitive Function in Cancer Patients". This research seeks to determine if a combination of low-dose ibuprofen along with a structured home-based walking and progressive resistance exercise program, EXCAP, will be effective in reducing cognitive difficulties among cancer patients receiving chemotherapy.
What is the current status of trial NCT01238120?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 110 participants. The study started on 2010-11. Estimated completion is 2020-12.
What interventions are being tested in trial NCT01238120?
The interventions under investigation include: Placebo (DRUG), Ibuprofen (DRUG), Home-Based Exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT01238120?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.